Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel agents for urological disorders disclosed in recent Dainippon Sumitomo patent

Aug. 29, 2006

Recent Janssen and Taiho patents describe new compounds for urological disorders

Aug. 16, 2006

Terlipressin fails to meet primary endpoint in type 1 hepatorenal syndrome study

Aug. 8, 2006

Phase IIb study planned for elocalcitol in overactive bladder

Aug. 1, 2006

German approval for new phosphate binding agent OsvaRen

July 25, 2006

TH-070 fails to meet endpoint in BPH phase II and phase III trials

July 19, 2006

Anti-PDGF-D monoclonal antibody may help delay mesangioproliferative nephritis progression

July 17, 2006

Sanctura XR reduces overactive bladder symptoms with good tolerability

July 11, 2006

First collaborative compound from Actelion and Merck renin alliance enters clinic

July 7, 2006

Micardis filed in Japan for type 2 diabetic nephropathy

July 5, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...